This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Lupin, Inc., Lupin Atlantis Holdings Sa. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Maharashtra, IN (2016)
- Pune, IN (2016 - 2017)
Company Filing History:
Years Active: 2016-2017
Title: Ramesh Dattatraya Phadtare: Innovator in Calcium Sensing Receptor Modulation
Introduction
Ramesh Dattatraya Phadtare is an accomplished inventor based in Pune, India, known for his significant contributions to pharmaceutical advancements. With a portfolio of three patents, Phadtare's work primarily focuses on the modulation of calcium sensing receptors, a vital area in medical therapeutics.
Latest Patents
Among his latest innovations, Phadtare has developed a series of arylalkylamine compounds that serve as calcium sensing receptor modulators (CaSR). This invention is noteworthy for its potential to treat, manage, and lessen the severity of various diseases associated with the modulation of CaSR. Additionally, he has introduced substituted morpholines that similarly function as modulators for calcium sensing receptors, detailing methods for their preparation and application in treating related health conditions.
Career Highlights
Phadtare has had an impressive career with notable companies such as Lupin, Inc. and Lupin Atlantis Holdings SA. His experience in these organizations has enriched his expertise, allowing him to cultivate a profound understanding of pharmaceutical science and innovation.
Collaborations
Throughout his career, Phadtare has collaborated with esteemed colleagues, including Manojkumar Ramprasad Shukla and Vinod Dinkar Chaudhari. These partnerships have contributed to the successful development and application of his inventions in the pharmaceutical field.
Conclusion
Ramesh Dattatraya Phadtare stands out as a significant figure in the realm of innovation, particularly in the treatment of conditions associated with calcium sensing receptors. His patents not only reflect his dedication to improving healthcare but also embody a commitment to advancing pharmaceutical research for the betterment of society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
